StockNews.com started coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Free Report) in a report published on Saturday. The brokerage issued a sell rating on the stock.
Ampio Pharmaceuticals Price Performance
Shares of NYSE AMPE opened at $0.13 on Friday. Ampio Pharmaceuticals has a 1-year low of $0.13 and a 1-year high of $8.30. The business’s 50 day moving average is $0.36 and its two-hundred day moving average is $1.33. The stock has a market capitalization of $147,550.00, a P/E ratio of -0.01 and a beta of 2.15.
Ampio Pharmaceuticals (NYSE:AMPE – Get Free Report) last released its earnings results on Wednesday, March 27th. The company reported ($2.48) earnings per share for the quarter.
Ampio Pharmaceuticals Company Profile
Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.
Featured Articles
- Five stocks we like better than Ampio Pharmaceuticals
- Top Biotech Stocks: Exploring Innovation Opportunities
- Our Comprehensive Risk Tolerance Assessment
- What is the Dow Jones Industrial Average (DJIA)?
- Autodesk Raises Guidance After Clearing Audit Investigation
- How is Compound Interest Calculated?
- Lyft Stock Gap and Craps on Bold 2027 Guidance at Investor Day
Receive News & Ratings for Ampio Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
